Rheumatic immune‐related adverse events induced by immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) block the major inhibitory pathways in T cells, resulting in an augmented antitumor response. Immune‐related adverse events (irAEs) are a new class of side effects caused by ICIs and tend to be more prevalent in patients with preexisting autoantibodies and autoimm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Hui, Zhou, Jiaxin, Xu, Dong, Zeng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246553/
https://www.ncbi.nlm.nih.gov/pubmed/32717098
http://dx.doi.org/10.1111/ajco.13346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246553/
https://www.ncbi.nlm.nih.gov/pubmed/32717098
http://dx.doi.org/10.1111/ajco.13346

Ejemplares similares